Dermoscopic findings of perifollicular pigmentation associated with vandetanib

Dermoscopic findings of perifollicular pigmentation associated with vandetanib

Authors

  • Jade Cury-Martins Department of Dermatology, University of São Paulo, São Paulo, Brazil
  • Jose Antonio Sanches Department of Dermatology, University of São Paulo, São Paulo, Brazil

Keywords:

cutaneous adverse events, tyrosine kinase inhibitor, pigmentation, dermoscopy

Downloads

Published

2018-10-31

Issue

Section

Letter

How to Cite

1.
Cury-Martins J, Sanches JA. Dermoscopic findings of perifollicular pigmentation associated with vandetanib. Dermatol Pract Concept. 2018;8(4):340-341. doi:10.5826/dpc.0804a20

Share